作者:Kristin M. Brinner、Mary Ann Powles、Dennis M. Schmatz、Jonathan A. Ellman
DOI:10.1016/j.bmcl.2004.10.069
日期:2005.1
A series of compounds with potent activity against a multi-drug-resistant strain of Plasmodium falciparum, the causative agent of the deadliest strain of malaria, is described. These compounds were also tested for cytotoxicity in human foreskin fibroblast assays, evaluated to determine their logD, and assayed for metabolism by human and murine hepatocytes. This work resulted in the development of compounds
描述了一系列对具有多重耐药性的恶性疟原虫具有有效活性的化合物,恶性疟原虫是最致命的疟疾菌株的病原体。还在人的包皮成纤维细胞测定中测试了这些化合物的细胞毒性,对其进行了评估以确定其logD,并通过人和鼠的肝细胞进行了代谢测定。这项工作导致了化合物9e和10d的开发,这些化合物显示出良好的效价(分别针对Dd2的IC(50)= 75 nM和<60 nM),可接受的logD值和合理的代谢稳定性。